Buchumschlag

VOC‐based detection of prostate cancer using an electronic nose and ion mobility spectrometry: A novel urine‐based approach

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Hendrik Heers, Oliver Chwilka, Johannes Huber, Claus Vogelmeier, Andreas Rembert Koczulla, Jörg Ingo Baumbach, Tobias Boeselt
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	The Prostate
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Key learnings from concordant systematic biopsies in prostate‐specific membrane antigen positron emission tomography/computed tomography‐guided prostate biopsies: Enhancing targeting accuracy
von: Thomas Büttner, et al.
Veröffentlicht: (2024)

The detection rate for prostate cancer in systematic and targeted prostate biopsy in biopsy‐naive patients, according to the localization of the lesion at the mpMRI: A single‐center retrospective observational study
von: Matteo Massanova, et al.
Veröffentlicht: (2024)

LGALS3 cfDNA methylation in seminal fluid as a novel prostate cancer biomarker outperforming PSA
von: Irena Abramovic, et al.
Veröffentlicht: (2024)

Modern predictors and management of incidental prostate cancer at holmium enucleation of prostate
von: Eric V. Li, et al.
Veröffentlicht: (2024)

Bellmunt risk score as a survival predictor in patients with metastatic castration‐resistant prostate cancer
von: Thomas Büttner, et al.
Veröffentlicht: (2024)

Size and SUVmax define the contribution of nodal metastases to PSA in oligorecurrent prostate cancer
von: Fabian Falkenbach, et al.
Veröffentlicht: (2024)

Does larger prostate size provide protection for cancer specific outcomes in localized prostate cancer
von: Zain Abedali, et al.
Veröffentlicht: (2024)

The predictive impact of hematological inflammatory markers in detecting prostate cancer in patients with PI‐RADS 3 lesions on multiparametric magnetic resonance imaging
von: Ridvan Kayar, et al.
Veröffentlicht: (2024)

Cutibacterium acnes invades prostate epithelial cells to induce BRCAness as a possible pathogen of prostate cancer
von: Shingo Ashida, et al.
Veröffentlicht: (2024)

A panel‐based mutational signature of homologous recombination deficiency associates with response to PARP inhibition in metastatic castration‐resistant prostate cancer
von: Daniel Boiarsky, et al.
Veröffentlicht: (2024)

A novel HDAC6 inhibitor interferes microtubule dynamics and spindle assembly checkpoint and sensitizes cisplatin‐induced apoptosis in castration‐resistant prostate cancer
von: Pei‐Chen Ye, et al.
Veröffentlicht: (2024)

Diagnosis and management of neuroendocrine prostate cancer
von: Ivan de Kouchkovsky, et al.
Veröffentlicht: (2024)

Bimodal imaging: Detection rate of clinically significant prostate cancer is higher in MRI lesions visible to transrectal ultrasound
von: Fabian Falkenbach, et al.
Veröffentlicht: (2024)

Other‐cause mortality in incidental prostate cancer
von: Francesco Di Bello, et al.
Veröffentlicht: (2024)

Influence of microbiome in intraprostatic inflammation and prostate cancer
von: Pranav Prakash, et al.
Veröffentlicht: (2024)

Consistent predictive ability of prostate‐specific antigen density prediction model for clinically significant prostate cancer across age strata
von: Kamil Malshy, et al.
Veröffentlicht: (2024)

Analysis of three primary prostatic sarcoma cases and literature review
von: Yirui Wei, et al.
Veröffentlicht: (2024)

FOXA1 regulates ribosomal RNA transcription in prostate cancer
von: Tianwei Jia, et al.
Veröffentlicht: (2024)

Translation and validation of a lifestyle questionnaire related to prostate cancer
von: Reyhane Karegar‐Niavol, et al.
Veröffentlicht: (2024)

The role of gut microbiota involved in prostate microenvironment and symptoms improvement in chronic prostatitis/chronic pelvic pain syndrome patients treated with low‐intensity extracorporeal shock wave
von: Xiangbin Kong, et al.
Veröffentlicht: (2024)

Investigation of pelvic floor influence on prostate displacement in image‐guided radiotherapy
von: Hongbo Chai, et al.
Veröffentlicht: (2024)

Three‐dimensional ultrastructural and anatomical analysis of prostatic neuroendocrine cells in mice
von: Kei‐Ichiro Uemura, et al.
Veröffentlicht: (2024)

Ejaculatory and erectile function outcomes following holmium laser enucleation of the prostate
von: Chinade Roper, et al.
Veröffentlicht: (2024)

Retrospective analysis of the learning curve in perineal robot‐assisted prostate biopsy
von: Ruth Himmelsbach, et al.
Veröffentlicht: (2024)

Cumulative cancer locations on prostate biopsy and active surveillance outcomes in the MRI era
von: Sean A. Fletcher, et al.
Veröffentlicht: (2024)

Lower urinary tract symptoms in elderly men: Considerations for prostate cancer testing
von: Stephen Schmit, et al.
Veröffentlicht: (2024)

Performance of large language models on benign prostatic hyperplasia frequently asked questions
von: YuNing Zhang, et al.
Veröffentlicht: (2024)

L1CAM mediates neuroendocrine phenotype acquisition in prostate cancer cells
von: Chia‐Ling Hsieh, et al.
Veröffentlicht: (2024)

Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix
von: Shuhei Kamada, et al.
Veröffentlicht: (2024)

Development and validation of an imageless machine‐learning algorithm for the initial screening of prostate cancer
von: Nicolas Martelin, et al.
Veröffentlicht: (2024)

Distribution of neurovascular structures within the prostate gland and their relationship to complications after radical prostatectomy
von: Ghazi Alanazi, et al.
Veröffentlicht: (2024)

Outcomes of 10 years of PSA screening for prostate cancer in Norwegian men with Lynch syndrome
von: Eli Marie Grindedal, et al.
Veröffentlicht: (2024)

Assessing state‐of‐the‐art online large language models for patient education regarding prostatitis
von: Pengfei Zhang, et al.
Veröffentlicht: (2024)

Serum levels of prostate specific antigen, free PSA, [−2]proPSA, fPSA/tPSA ratio, Prostate Health Index, and glycosylation patterns of free PSA in patients with benign prostatic hyperplasia pharmacotherapy
von: Michal Jirásko, et al.
Veröffentlicht: (2024)

Real‐world study: Impact of multidisciplinary management of apalutamide‐associated adverse events in prostate cancer
von: Julián Córdoba Sánchez, et al.
Veröffentlicht: (2024)

Comparison of abiraterone, enzalutamide, and apalutamide for metastatic hormone‐sensitive prostate cancer: A multicenter study
von: Takafumi Yanagisawa, et al.
Veröffentlicht: (2024)

PIK3/Akt/mTOR pathway alterations in metastatic castration‐sensitive prostate cancer
von: Philip Sutera, et al.
Veröffentlicht: (2024)

Machine learning and explainable artificial intelligence to predict pathologic stage in men with localized prostate cancer
von: Hemal Semwal, et al.
Veröffentlicht: (2024)

Minimally invasive surgical therapies for benign prostatic hyperplasia in the geriatric population: A systematic review
von: Ahmad Abid, et al.
Veröffentlicht: (2024)

An orthotopic prostate cancer model for new treatment development using syngeneic or patient‐derived tumors
von: Naz Chaudary, et al.
Veröffentlicht: (2024)